Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol Dose Finding and Efficacy in COPD
NCT00463567Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of indacaterol in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Apr 2007; status: completed.
02
Drugs
indacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00463567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463567.